Thiosulfuric Acid

Thiosulfuric Acid

SCHEMBL146659

O=S([O-])([O-])=S.O=S([O-])([O-])=S.[Au+3].[Na+]

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Thiosulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.46
ALDH1A1 P00352 1/20 0.46
TSHR P16473 1/20 0.46
KMT2A Q03164 1/20 0.46
KDM4E B2RXH2 1/20 0.32
MAPT P10636 1/20 0.32
ALOX15 P16050 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Thiosulfuric Acid SCHEMBL828950 1.00 MEN1 (0.46) MEN1ALDH1A1TSHRKMT2AKDM4E
Thiosulfuric Acid SCHEMBL31090016 1.00
Thiosulfuric Acid SCHEMBL28476703 0.95 MEN1 (0.43) MEN1ALDH1A1TSHRKMT2AKDM4E
Thiosulfuric Acid SCHEMBL896433 0.95 MEN1 (0.43) MEN1ALDH1A1TSHRKMT2AKDM4E
Thiosulfuric Acid SCHEMBL11787332 0.95 ALDH1A1 (0.50) MEN1ALDH1A1TSHRKMT2AKDM4E
Thiosulfuric Acid SCHEMBL4088 0.95
Thiosulfuric Acid SCHEMBL27724216 0.95 ALDH1A1 (0.50) MEN1ALDH1A1TSHRKMT2AKDM4E
Thiosulfuric Acid SCHEMBL11200821 0.95 ALDH1A1 (0.50) MEN1ALDH1A1TSHRKMT2AKDM4E
Thiosulfuric Acid SCHEMBL337690 0.95 MEN1 (0.39) MEN1ALDH1A1TSHRKMT2A
Thiosulfuric Acid SCHEMBL7156513 0.90 MEN1 (0.36) MEN1ALDH1A1TSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 616 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117324621-B Surface-modified gold magnetic nanoparticle and preparation method and application thereof 杭州珞米医疗科技有限公司 2025-04-01 CN claimed
US-20250099590-A1 HIGH DENSITY ULTRASOUND COUPLING GEL AND METHODS OF USE THEREOF ZETROZ SYSTEMS LLC (US) 2025-03-27 US claimed
CN-118223015-B Gold precipitation solution for electroless gold plating and preparation method thereof 珠海斯美特电子材料有限公司 2025-03-14 CN claimed
CN-119425689-A Catalyst for synthesizing hydrogen peroxide and preparation method and application thereof 中国石油化工股份有限公司 2025-02-14 CN claimed
CN-116174032-B Anti-loss gold-based catalyst and preparation method and application thereof 内蒙古鄂尔多斯电力冶金集团股份有限公司 2025-01-28 CN claimed
CN-118703405-B Mineralized microorganism and preparation and application thereof 南京大学 2025-01-03 CN claimed
CN-115710701-B Electroless gold plating solution and application 广东东硕科技有限公司 2024-12-10 CN claimed
US-20240377333-A1 NOBLE METAL-CONTAINING COMPOUND DETECTION BY CATALYSIS OF OPTICAL DYE REDUCTION BECTON DICKINSON CO (US) 2024-11-14 US claimed
CN-116159579-B Acetylene hydrochlorination low-temperature mercury-free catalyst and preparation method thereof 内蒙古鄂尔多斯电力冶金集团股份有限公司 2024-11-01 CN claimed
US-12117447-B2 Metal nanoparticles and methods of making same Sona Nanotech Inc. (CA) 2024-10-15 US claimed
US-20150174160-A1 METHODS FOR TREATING, DIAGNOSING AND/OR MONITORING PROGRESSION OF OXO ASSOCIATED STATES PRAVDA JAY (US) 2015-06-25 US claimed
EP-2866565-A2 METHODS FOR TREATING, DIAGNOSING AND/OR MONITORING PROGRESSION OF OXO ASSOCIATED STATES Pravda, Jay (US) 2015-05-06 EP claimed
US-20140335205-A1 MATERIALS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS THERAPEUTIC RES LLC (US) 2014-11-13 US claimed
WO-2014008273-A2 METHODS FOR TREATING, DIAGNOSING AND/OR MONITORING PROGRESSION OF OXO ASSOCIATED STATES PRAVDA JAY (US) 2014-01-09 WO claimed
US-20120322773-A1 MATERIALS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS PRAVDA JAY (US) 2012-12-20 US claimed
US-20100112088-A1 MATERIALS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS PRAVDA JAY 2010-05-06 US claimed
US-4657763-A TREATMENT OF RHEUMATOID ARTHRITIS BY SYNERGISTIC ACTIONS OF DIFFERENT GOLD COMPOUNDS Ebert, Michael (US) 1987-04-14 US claimed
EP-0054997-B1 ANTI-ARTHRITIC COMPOSITIONS CONTAINING GOLD SALTS AND ORGANOPHOSPHONATES THE PROCTER & GAMBLE COMPANY (US) 1986-03-12 EP claimed
EP-0054997-A1 Anti-arthritic compositions containing gold salts and organophosphonates THE PROCTER & GAMBLE COMPANY (US) 1982-06-30 EP claimed
US-4330530-A Anti-arthritic compositions and method using gold salts and organophosphonates THE PROCTER & GAMBLE COMPANY (US) 1982-05-18 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120322773-A1 MATERIALS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS LPO, ALOX15B, ALOX15 MEN1 3706/4885ALDH1A1 96/4885TSHR 4873/4885
US-20140335205-A1 MATERIALS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS TXN, GPX4, TXN2 MEN1 4690/4885ALDH1A1 379/4885TSHR 4546/4885
US-20100112088-A1 MATERIALS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS TXN, GPX4, TXN2 MEN1 4690/4885ALDH1A1 379/4885TSHR 4546/4885
US-12117447-B2 Metal nanoparticles and methods of making same SOD1, SLC39A3, SLC30A7 MEN1 810/4885ALDH1A1 2356/4885TSHR 2680/4885
US-20150174160-A1 METHODS FOR TREATING, DIAGNOSING AND/OR MONITORING PROGRESSION OF OXO ASSOCIATED STATES OAT, OTC, HOGA1 MEN1 3440/4885ALDH1A1 885/4885TSHR 3364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.